PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.\', \'Department of Infectious Diseases, Yokohama Municipal Citizen\'s Hospital, Yokohama, Kanagawa, Japan.\', \'Department of Respiratory Medicine, Yokohama Municipal Citizen\'s Hospital, Yokohama, Kanagawa, Japan.\', \'Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.\', \'Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.\', \'Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.\', \'Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0254640
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34255796
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all